Global AI Imaging & Diagnostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global AI Imaging & Diagnostics market size was valued at US$ 7469 million in 2025 and is forecast to a readjusted size of US$ 27568 million by 2032 with a CAGR of 20.4% during review period.
AI Imaging & Diagnostics refers to the integrated market of artificial intelligence technologies applied to medical imaging analysis and broader clinical diagnostic decision-making. It includes AI systems that analyze imaging data such as X-ray, CT, MRI, ultrasound, mammography, and digital pathology, as well as solutions that combine imaging with non-imaging clinical inputs (e.g., physiological signals, structured EHR data) to support diagnosis. These products are typically commercialized as regulated Software as a Medical Device (SaMD) or embedded into imaging equipment and clinical IT systems such as PACS, RIS, and EHRs. AI Imaging & Diagnostics enhances diagnostic accuracy, standardization, and efficiency while keeping physicians in the loop, addressing rising imaging volumes, workforce shortages, and the need for earlier and more consistent disease detection.
The market can be classified by data type (imaging-based, signal-based, multi-modal), by clinical function (detection, segmentation, classification, severity scoring, diagnostic recommendation), by medical specialty (radiology, cardiology, oncology, neurology, ophthalmology, primary care), by deployment model (on-premise, cloud SaaS, device-embedded, edge-based), and by regulatory/commercial type (standalone SaMD, bundled software, clinical decision support, screening-focused solutions). These dimensions reflect both technical complexity and commercial pathways.
Key costs arise from data acquisition and labeling, algorithm development, clinical trials, regulatory compliance, and continuous model updates. With software-centric economics, gross margins generally range from 65% to 80%. Transactions are dominated by subscription SaaS, per-study pricing, and multi-year enterprise licenses, often bundled with imaging systems or workflow platforms. Market trends include rapid regulatory approvals, consolidation through M&A, deeper OEM integration, expansion beyond radiology into multi-disciplinary diagnostics, and accelerating adoption driven by value-based care and clinician shortages.
This report is a detailed and comprehensive analysis for global AI Imaging & Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Imaging & Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Imaging & Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Imaging & Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Imaging & Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Imaging & Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Imaging & Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Butterfly Network, Merative, Tempus, RetinAi, Nanox, Lunit, DiA Imaging, Subtle Medical, BrainMiner, GE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Imaging & Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Imaging & Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Imaging & Diagnostics, with revenue, gross margin, and global market share of AI Imaging & Diagnostics from 2021 to 2026.
Chapter 3, the AI Imaging & Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Imaging & Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Imaging & Diagnostics.
Chapter 13, to describe AI Imaging & Diagnostics research findings and conclusion.
AI Imaging & Diagnostics refers to the integrated market of artificial intelligence technologies applied to medical imaging analysis and broader clinical diagnostic decision-making. It includes AI systems that analyze imaging data such as X-ray, CT, MRI, ultrasound, mammography, and digital pathology, as well as solutions that combine imaging with non-imaging clinical inputs (e.g., physiological signals, structured EHR data) to support diagnosis. These products are typically commercialized as regulated Software as a Medical Device (SaMD) or embedded into imaging equipment and clinical IT systems such as PACS, RIS, and EHRs. AI Imaging & Diagnostics enhances diagnostic accuracy, standardization, and efficiency while keeping physicians in the loop, addressing rising imaging volumes, workforce shortages, and the need for earlier and more consistent disease detection.
The market can be classified by data type (imaging-based, signal-based, multi-modal), by clinical function (detection, segmentation, classification, severity scoring, diagnostic recommendation), by medical specialty (radiology, cardiology, oncology, neurology, ophthalmology, primary care), by deployment model (on-premise, cloud SaaS, device-embedded, edge-based), and by regulatory/commercial type (standalone SaMD, bundled software, clinical decision support, screening-focused solutions). These dimensions reflect both technical complexity and commercial pathways.
Key costs arise from data acquisition and labeling, algorithm development, clinical trials, regulatory compliance, and continuous model updates. With software-centric economics, gross margins generally range from 65% to 80%. Transactions are dominated by subscription SaaS, per-study pricing, and multi-year enterprise licenses, often bundled with imaging systems or workflow platforms. Market trends include rapid regulatory approvals, consolidation through M&A, deeper OEM integration, expansion beyond radiology into multi-disciplinary diagnostics, and accelerating adoption driven by value-based care and clinician shortages.
This report is a detailed and comprehensive analysis for global AI Imaging & Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Imaging & Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Imaging & Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Imaging & Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Imaging & Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Imaging & Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Imaging & Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Butterfly Network, Merative, Tempus, RetinAi, Nanox, Lunit, DiA Imaging, Subtle Medical, BrainMiner, GE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Imaging & Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- X-ray / CXR
- CT
- MRI
- Ultrasound
- Mammography / DBT
- Others
- Medical Imaging–based
- Physiological Signals–based
- Ophthalmic Imaging–based
- Others
- On-prem
- Cloud SaaS
- Edge / Embedded
- Hybrid
- Others
- Radiology & Imaging
- Cardiology
- Neurology
- Ophthalmology
- Oncology
- Primary Care
- Others
- Butterfly Network
- Merative
- Tempus
- RetinAi
- Nanox
- Lunit
- DiA Imaging
- Subtle Medical
- BrainMiner
- GE
- Siemens
- Aidoc
- Imagen Technologies, Inc.
- VUNO, Inc.
- Digital Diagnostics
- NeuraSignal
- Riverain Technologies, LLC
- Philips
- Microsoft
- Viz.ai
- RapidAI
- Canon Medical
- Enlitic
- BioMind
- ANNALISE-AI PTY LTD
- icometrix
- KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Imaging & Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Imaging & Diagnostics, with revenue, gross margin, and global market share of AI Imaging & Diagnostics from 2021 to 2026.
Chapter 3, the AI Imaging & Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Imaging & Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Imaging & Diagnostics.
Chapter 13, to describe AI Imaging & Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Imaging & Diagnostics by Type
1.3.1 Overview: Global AI Imaging & Diagnostics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global AI Imaging & Diagnostics Consumption Value Market Share by Type in 2025
1.3.3 X-ray / CXR
1.3.4 CT
1.3.5 MRI
1.3.6 Ultrasound
1.3.7 Mammography / DBT
1.3.8 Others
1.4 Classification of AI Imaging & Diagnostics by Diagnostic Data Type
1.4.1 Overview: Global AI Imaging & Diagnostics Market Size by Diagnostic Data Type: 2021 Versus 2025 Versus 2032
1.4.2 Global AI Imaging & Diagnostics Consumption Value Market Share by Diagnostic Data Type in 2025
1.4.3 Medical Imaging–based
1.4.4 Physiological Signals–based
1.4.5 Ophthalmic Imaging–based
1.4.6 Others
1.5 Classification of AI Imaging & Diagnostics by Deployment & Delivery
1.5.1 Overview: Global AI Imaging & Diagnostics Market Size by Deployment & Delivery: 2021 Versus 2025 Versus 2032
1.5.2 Global AI Imaging & Diagnostics Consumption Value Market Share by Deployment & Delivery in 2025
1.5.3 On-prem
1.5.4 Cloud SaaS
1.5.5 Edge / Embedded
1.5.6 Hybrid
1.5.7 Others
1.6 Global AI Imaging & Diagnostics Market by Application
1.6.1 Overview: Global AI Imaging & Diagnostics Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Radiology & Imaging
1.6.3 Cardiology
1.6.4 Neurology
1.6.5 Ophthalmology
1.6.6 Oncology
1.6.7 Primary Care
1.6.8 Others
1.7 Global AI Imaging & Diagnostics Market Size & Forecast
1.8 Global AI Imaging & Diagnostics Market Size and Forecast by Region
1.8.1 Global AI Imaging & Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global AI Imaging & Diagnostics Market Size by Region, (2021-2032)
1.8.3 North America AI Imaging & Diagnostics Market Size and Prospect (2021-2032)
1.8.4 Europe AI Imaging & Diagnostics Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific AI Imaging & Diagnostics Market Size and Prospect (2021-2032)
1.8.6 South America AI Imaging & Diagnostics Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa AI Imaging & Diagnostics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Butterfly Network
2.1.1 Butterfly Network Details
2.1.2 Butterfly Network Major Business
2.1.3 Butterfly Network AI Imaging & Diagnostics Product and Solutions
2.1.4 Butterfly Network AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Butterfly Network Recent Developments and Future Plans
2.2 Merative
2.2.1 Merative Details
2.2.2 Merative Major Business
2.2.3 Merative AI Imaging & Diagnostics Product and Solutions
2.2.4 Merative AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Merative Recent Developments and Future Plans
2.3 Tempus
2.3.1 Tempus Details
2.3.2 Tempus Major Business
2.3.3 Tempus AI Imaging & Diagnostics Product and Solutions
2.3.4 Tempus AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Tempus Recent Developments and Future Plans
2.4 RetinAi
2.4.1 RetinAi Details
2.4.2 RetinAi Major Business
2.4.3 RetinAi AI Imaging & Diagnostics Product and Solutions
2.4.4 RetinAi AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 RetinAi Recent Developments and Future Plans
2.5 Nanox
2.5.1 Nanox Details
2.5.2 Nanox Major Business
2.5.3 Nanox AI Imaging & Diagnostics Product and Solutions
2.5.4 Nanox AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Nanox Recent Developments and Future Plans
2.6 Lunit
2.6.1 Lunit Details
2.6.2 Lunit Major Business
2.6.3 Lunit AI Imaging & Diagnostics Product and Solutions
2.6.4 Lunit AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Lunit Recent Developments and Future Plans
2.7 DiA Imaging
2.7.1 DiA Imaging Details
2.7.2 DiA Imaging Major Business
2.7.3 DiA Imaging AI Imaging & Diagnostics Product and Solutions
2.7.4 DiA Imaging AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 DiA Imaging Recent Developments and Future Plans
2.8 Subtle Medical
2.8.1 Subtle Medical Details
2.8.2 Subtle Medical Major Business
2.8.3 Subtle Medical AI Imaging & Diagnostics Product and Solutions
2.8.4 Subtle Medical AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Subtle Medical Recent Developments and Future Plans
2.9 BrainMiner
2.9.1 BrainMiner Details
2.9.2 BrainMiner Major Business
2.9.3 BrainMiner AI Imaging & Diagnostics Product and Solutions
2.9.4 BrainMiner AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 BrainMiner Recent Developments and Future Plans
2.10 GE
2.10.1 GE Details
2.10.2 GE Major Business
2.10.3 GE AI Imaging & Diagnostics Product and Solutions
2.10.4 GE AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 GE Recent Developments and Future Plans
2.11 Siemens
2.11.1 Siemens Details
2.11.2 Siemens Major Business
2.11.3 Siemens AI Imaging & Diagnostics Product and Solutions
2.11.4 Siemens AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Siemens Recent Developments and Future Plans
2.12 Aidoc
2.12.1 Aidoc Details
2.12.2 Aidoc Major Business
2.12.3 Aidoc AI Imaging & Diagnostics Product and Solutions
2.12.4 Aidoc AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Aidoc Recent Developments and Future Plans
2.13 Imagen Technologies, Inc.
2.13.1 Imagen Technologies, Inc. Details
2.13.2 Imagen Technologies, Inc. Major Business
2.13.3 Imagen Technologies, Inc. AI Imaging & Diagnostics Product and Solutions
2.13.4 Imagen Technologies, Inc. AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Imagen Technologies, Inc. Recent Developments and Future Plans
2.14 VUNO, Inc.
2.14.1 VUNO, Inc. Details
2.14.2 VUNO, Inc. Major Business
2.14.3 VUNO, Inc. AI Imaging & Diagnostics Product and Solutions
2.14.4 VUNO, Inc. AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 VUNO, Inc. Recent Developments and Future Plans
2.15 Digital Diagnostics
2.15.1 Digital Diagnostics Details
2.15.2 Digital Diagnostics Major Business
2.15.3 Digital Diagnostics AI Imaging & Diagnostics Product and Solutions
2.15.4 Digital Diagnostics AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Digital Diagnostics Recent Developments and Future Plans
2.16 NeuraSignal
2.16.1 NeuraSignal Details
2.16.2 NeuraSignal Major Business
2.16.3 NeuraSignal AI Imaging & Diagnostics Product and Solutions
2.16.4 NeuraSignal AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 NeuraSignal Recent Developments and Future Plans
2.17 Riverain Technologies, LLC
2.17.1 Riverain Technologies, LLC Details
2.17.2 Riverain Technologies, LLC Major Business
2.17.3 Riverain Technologies, LLC AI Imaging & Diagnostics Product and Solutions
2.17.4 Riverain Technologies, LLC AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Riverain Technologies, LLC Recent Developments and Future Plans
2.18 Philips
2.18.1 Philips Details
2.18.2 Philips Major Business
2.18.3 Philips AI Imaging & Diagnostics Product and Solutions
2.18.4 Philips AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Philips Recent Developments and Future Plans
2.19 Microsoft
2.19.1 Microsoft Details
2.19.2 Microsoft Major Business
2.19.3 Microsoft AI Imaging & Diagnostics Product and Solutions
2.19.4 Microsoft AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Microsoft Recent Developments and Future Plans
2.20 Viz.ai
2.20.1 Viz.ai Details
2.20.2 Viz.ai Major Business
2.20.3 Viz.ai AI Imaging & Diagnostics Product and Solutions
2.20.4 Viz.ai AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Viz.ai Recent Developments and Future Plans
2.21 RapidAI
2.21.1 RapidAI Details
2.21.2 RapidAI Major Business
2.21.3 RapidAI AI Imaging & Diagnostics Product and Solutions
2.21.4 RapidAI AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 RapidAI Recent Developments and Future Plans
2.22 Canon Medical
2.22.1 Canon Medical Details
2.22.2 Canon Medical Major Business
2.22.3 Canon Medical AI Imaging & Diagnostics Product and Solutions
2.22.4 Canon Medical AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Canon Medical Recent Developments and Future Plans
2.23 Enlitic
2.23.1 Enlitic Details
2.23.2 Enlitic Major Business
2.23.3 Enlitic AI Imaging & Diagnostics Product and Solutions
2.23.4 Enlitic AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Enlitic Recent Developments and Future Plans
2.24 BioMind
2.24.1 BioMind Details
2.24.2 BioMind Major Business
2.24.3 BioMind AI Imaging & Diagnostics Product and Solutions
2.24.4 BioMind AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 BioMind Recent Developments and Future Plans
2.25 ANNALISE-AI PTY LTD
2.25.1 ANNALISE-AI PTY LTD Details
2.25.2 ANNALISE-AI PTY LTD Major Business
2.25.3 ANNALISE-AI PTY LTD AI Imaging & Diagnostics Product and Solutions
2.25.4 ANNALISE-AI PTY LTD AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 ANNALISE-AI PTY LTD Recent Developments and Future Plans
2.26 icometrix
2.26.1 icometrix Details
2.26.2 icometrix Major Business
2.26.3 icometrix AI Imaging & Diagnostics Product and Solutions
2.26.4 icometrix AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 icometrix Recent Developments and Future Plans
2.27 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
2.27.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Details
2.27.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Major Business
2.27.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Imaging & Diagnostics Product and Solutions
2.27.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Imaging & Diagnostics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of AI Imaging & Diagnostics by Company Revenue
3.2.2 Top 3 AI Imaging & Diagnostics Players Market Share in 2025
3.2.3 Top 6 AI Imaging & Diagnostics Players Market Share in 2025
3.3 AI Imaging & Diagnostics Market: Overall Company Footprint Analysis
3.3.1 AI Imaging & Diagnostics Market: Region Footprint
3.3.2 AI Imaging & Diagnostics Market: Company Product Type Footprint
3.3.3 AI Imaging & Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Imaging & Diagnostics Consumption Value and Market Share by Type (2021-2026)
4.2 Global AI Imaging & Diagnostics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2026)
5.2 Global AI Imaging & Diagnostics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
6.2 North America AI Imaging & Diagnostics Market Size by Application (2021-2032)
6.3 North America AI Imaging & Diagnostics Market Size by Country
6.3.1 North America AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
6.3.2 United States AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
6.3.3 Canada AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
6.3.4 Mexico AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
7.2 Europe AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
7.3 Europe AI Imaging & Diagnostics Market Size by Country
7.3.1 Europe AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
7.3.2 Germany AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
7.3.3 France AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
7.3.5 Russia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
7.3.6 Italy AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific AI Imaging & Diagnostics Market Size by Region
8.3.1 Asia-Pacific AI Imaging & Diagnostics Consumption Value by Region (2021-2032)
8.3.2 China AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8.3.3 Japan AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8.3.4 South Korea AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8.3.5 India AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8.3.7 Australia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
9.2 South America AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
9.3 South America AI Imaging & Diagnostics Market Size by Country
9.3.1 South America AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
9.3.2 Brazil AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
9.3.3 Argentina AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa AI Imaging & Diagnostics Market Size by Country
10.3.1 Middle East & Africa AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
10.3.2 Turkey AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
10.3.4 UAE AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 AI Imaging & Diagnostics Market Drivers
11.2 AI Imaging & Diagnostics Market Restraints
11.3 AI Imaging & Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Imaging & Diagnostics Industry Chain
12.2 AI Imaging & Diagnostics Upstream Analysis
12.3 AI Imaging & Diagnostics Midstream Analysis
12.4 AI Imaging & Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Imaging & Diagnostics by Type
1.3.1 Overview: Global AI Imaging & Diagnostics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global AI Imaging & Diagnostics Consumption Value Market Share by Type in 2025
1.3.3 X-ray / CXR
1.3.4 CT
1.3.5 MRI
1.3.6 Ultrasound
1.3.7 Mammography / DBT
1.3.8 Others
1.4 Classification of AI Imaging & Diagnostics by Diagnostic Data Type
1.4.1 Overview: Global AI Imaging & Diagnostics Market Size by Diagnostic Data Type: 2021 Versus 2025 Versus 2032
1.4.2 Global AI Imaging & Diagnostics Consumption Value Market Share by Diagnostic Data Type in 2025
1.4.3 Medical Imaging–based
1.4.4 Physiological Signals–based
1.4.5 Ophthalmic Imaging–based
1.4.6 Others
1.5 Classification of AI Imaging & Diagnostics by Deployment & Delivery
1.5.1 Overview: Global AI Imaging & Diagnostics Market Size by Deployment & Delivery: 2021 Versus 2025 Versus 2032
1.5.2 Global AI Imaging & Diagnostics Consumption Value Market Share by Deployment & Delivery in 2025
1.5.3 On-prem
1.5.4 Cloud SaaS
1.5.5 Edge / Embedded
1.5.6 Hybrid
1.5.7 Others
1.6 Global AI Imaging & Diagnostics Market by Application
1.6.1 Overview: Global AI Imaging & Diagnostics Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Radiology & Imaging
1.6.3 Cardiology
1.6.4 Neurology
1.6.5 Ophthalmology
1.6.6 Oncology
1.6.7 Primary Care
1.6.8 Others
1.7 Global AI Imaging & Diagnostics Market Size & Forecast
1.8 Global AI Imaging & Diagnostics Market Size and Forecast by Region
1.8.1 Global AI Imaging & Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global AI Imaging & Diagnostics Market Size by Region, (2021-2032)
1.8.3 North America AI Imaging & Diagnostics Market Size and Prospect (2021-2032)
1.8.4 Europe AI Imaging & Diagnostics Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific AI Imaging & Diagnostics Market Size and Prospect (2021-2032)
1.8.6 South America AI Imaging & Diagnostics Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa AI Imaging & Diagnostics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Butterfly Network
2.1.1 Butterfly Network Details
2.1.2 Butterfly Network Major Business
2.1.3 Butterfly Network AI Imaging & Diagnostics Product and Solutions
2.1.4 Butterfly Network AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Butterfly Network Recent Developments and Future Plans
2.2 Merative
2.2.1 Merative Details
2.2.2 Merative Major Business
2.2.3 Merative AI Imaging & Diagnostics Product and Solutions
2.2.4 Merative AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Merative Recent Developments and Future Plans
2.3 Tempus
2.3.1 Tempus Details
2.3.2 Tempus Major Business
2.3.3 Tempus AI Imaging & Diagnostics Product and Solutions
2.3.4 Tempus AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Tempus Recent Developments and Future Plans
2.4 RetinAi
2.4.1 RetinAi Details
2.4.2 RetinAi Major Business
2.4.3 RetinAi AI Imaging & Diagnostics Product and Solutions
2.4.4 RetinAi AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 RetinAi Recent Developments and Future Plans
2.5 Nanox
2.5.1 Nanox Details
2.5.2 Nanox Major Business
2.5.3 Nanox AI Imaging & Diagnostics Product and Solutions
2.5.4 Nanox AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Nanox Recent Developments and Future Plans
2.6 Lunit
2.6.1 Lunit Details
2.6.2 Lunit Major Business
2.6.3 Lunit AI Imaging & Diagnostics Product and Solutions
2.6.4 Lunit AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Lunit Recent Developments and Future Plans
2.7 DiA Imaging
2.7.1 DiA Imaging Details
2.7.2 DiA Imaging Major Business
2.7.3 DiA Imaging AI Imaging & Diagnostics Product and Solutions
2.7.4 DiA Imaging AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 DiA Imaging Recent Developments and Future Plans
2.8 Subtle Medical
2.8.1 Subtle Medical Details
2.8.2 Subtle Medical Major Business
2.8.3 Subtle Medical AI Imaging & Diagnostics Product and Solutions
2.8.4 Subtle Medical AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Subtle Medical Recent Developments and Future Plans
2.9 BrainMiner
2.9.1 BrainMiner Details
2.9.2 BrainMiner Major Business
2.9.3 BrainMiner AI Imaging & Diagnostics Product and Solutions
2.9.4 BrainMiner AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 BrainMiner Recent Developments and Future Plans
2.10 GE
2.10.1 GE Details
2.10.2 GE Major Business
2.10.3 GE AI Imaging & Diagnostics Product and Solutions
2.10.4 GE AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 GE Recent Developments and Future Plans
2.11 Siemens
2.11.1 Siemens Details
2.11.2 Siemens Major Business
2.11.3 Siemens AI Imaging & Diagnostics Product and Solutions
2.11.4 Siemens AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Siemens Recent Developments and Future Plans
2.12 Aidoc
2.12.1 Aidoc Details
2.12.2 Aidoc Major Business
2.12.3 Aidoc AI Imaging & Diagnostics Product and Solutions
2.12.4 Aidoc AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Aidoc Recent Developments and Future Plans
2.13 Imagen Technologies, Inc.
2.13.1 Imagen Technologies, Inc. Details
2.13.2 Imagen Technologies, Inc. Major Business
2.13.3 Imagen Technologies, Inc. AI Imaging & Diagnostics Product and Solutions
2.13.4 Imagen Technologies, Inc. AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Imagen Technologies, Inc. Recent Developments and Future Plans
2.14 VUNO, Inc.
2.14.1 VUNO, Inc. Details
2.14.2 VUNO, Inc. Major Business
2.14.3 VUNO, Inc. AI Imaging & Diagnostics Product and Solutions
2.14.4 VUNO, Inc. AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 VUNO, Inc. Recent Developments and Future Plans
2.15 Digital Diagnostics
2.15.1 Digital Diagnostics Details
2.15.2 Digital Diagnostics Major Business
2.15.3 Digital Diagnostics AI Imaging & Diagnostics Product and Solutions
2.15.4 Digital Diagnostics AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Digital Diagnostics Recent Developments and Future Plans
2.16 NeuraSignal
2.16.1 NeuraSignal Details
2.16.2 NeuraSignal Major Business
2.16.3 NeuraSignal AI Imaging & Diagnostics Product and Solutions
2.16.4 NeuraSignal AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 NeuraSignal Recent Developments and Future Plans
2.17 Riverain Technologies, LLC
2.17.1 Riverain Technologies, LLC Details
2.17.2 Riverain Technologies, LLC Major Business
2.17.3 Riverain Technologies, LLC AI Imaging & Diagnostics Product and Solutions
2.17.4 Riverain Technologies, LLC AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Riverain Technologies, LLC Recent Developments and Future Plans
2.18 Philips
2.18.1 Philips Details
2.18.2 Philips Major Business
2.18.3 Philips AI Imaging & Diagnostics Product and Solutions
2.18.4 Philips AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Philips Recent Developments and Future Plans
2.19 Microsoft
2.19.1 Microsoft Details
2.19.2 Microsoft Major Business
2.19.3 Microsoft AI Imaging & Diagnostics Product and Solutions
2.19.4 Microsoft AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Microsoft Recent Developments and Future Plans
2.20 Viz.ai
2.20.1 Viz.ai Details
2.20.2 Viz.ai Major Business
2.20.3 Viz.ai AI Imaging & Diagnostics Product and Solutions
2.20.4 Viz.ai AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Viz.ai Recent Developments and Future Plans
2.21 RapidAI
2.21.1 RapidAI Details
2.21.2 RapidAI Major Business
2.21.3 RapidAI AI Imaging & Diagnostics Product and Solutions
2.21.4 RapidAI AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 RapidAI Recent Developments and Future Plans
2.22 Canon Medical
2.22.1 Canon Medical Details
2.22.2 Canon Medical Major Business
2.22.3 Canon Medical AI Imaging & Diagnostics Product and Solutions
2.22.4 Canon Medical AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Canon Medical Recent Developments and Future Plans
2.23 Enlitic
2.23.1 Enlitic Details
2.23.2 Enlitic Major Business
2.23.3 Enlitic AI Imaging & Diagnostics Product and Solutions
2.23.4 Enlitic AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Enlitic Recent Developments and Future Plans
2.24 BioMind
2.24.1 BioMind Details
2.24.2 BioMind Major Business
2.24.3 BioMind AI Imaging & Diagnostics Product and Solutions
2.24.4 BioMind AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 BioMind Recent Developments and Future Plans
2.25 ANNALISE-AI PTY LTD
2.25.1 ANNALISE-AI PTY LTD Details
2.25.2 ANNALISE-AI PTY LTD Major Business
2.25.3 ANNALISE-AI PTY LTD AI Imaging & Diagnostics Product and Solutions
2.25.4 ANNALISE-AI PTY LTD AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 ANNALISE-AI PTY LTD Recent Developments and Future Plans
2.26 icometrix
2.26.1 icometrix Details
2.26.2 icometrix Major Business
2.26.3 icometrix AI Imaging & Diagnostics Product and Solutions
2.26.4 icometrix AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 icometrix Recent Developments and Future Plans
2.27 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
2.27.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Details
2.27.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Major Business
2.27.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Imaging & Diagnostics Product and Solutions
2.27.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Imaging & Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Imaging & Diagnostics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of AI Imaging & Diagnostics by Company Revenue
3.2.2 Top 3 AI Imaging & Diagnostics Players Market Share in 2025
3.2.3 Top 6 AI Imaging & Diagnostics Players Market Share in 2025
3.3 AI Imaging & Diagnostics Market: Overall Company Footprint Analysis
3.3.1 AI Imaging & Diagnostics Market: Region Footprint
3.3.2 AI Imaging & Diagnostics Market: Company Product Type Footprint
3.3.3 AI Imaging & Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Imaging & Diagnostics Consumption Value and Market Share by Type (2021-2026)
4.2 Global AI Imaging & Diagnostics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2026)
5.2 Global AI Imaging & Diagnostics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
6.2 North America AI Imaging & Diagnostics Market Size by Application (2021-2032)
6.3 North America AI Imaging & Diagnostics Market Size by Country
6.3.1 North America AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
6.3.2 United States AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
6.3.3 Canada AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
6.3.4 Mexico AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
7.2 Europe AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
7.3 Europe AI Imaging & Diagnostics Market Size by Country
7.3.1 Europe AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
7.3.2 Germany AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
7.3.3 France AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
7.3.5 Russia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
7.3.6 Italy AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific AI Imaging & Diagnostics Market Size by Region
8.3.1 Asia-Pacific AI Imaging & Diagnostics Consumption Value by Region (2021-2032)
8.3.2 China AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8.3.3 Japan AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8.3.4 South Korea AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8.3.5 India AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
8.3.7 Australia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
9.2 South America AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
9.3 South America AI Imaging & Diagnostics Market Size by Country
9.3.1 South America AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
9.3.2 Brazil AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
9.3.3 Argentina AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Imaging & Diagnostics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa AI Imaging & Diagnostics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa AI Imaging & Diagnostics Market Size by Country
10.3.1 Middle East & Africa AI Imaging & Diagnostics Consumption Value by Country (2021-2032)
10.3.2 Turkey AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
10.3.4 UAE AI Imaging & Diagnostics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 AI Imaging & Diagnostics Market Drivers
11.2 AI Imaging & Diagnostics Market Restraints
11.3 AI Imaging & Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Imaging & Diagnostics Industry Chain
12.2 AI Imaging & Diagnostics Upstream Analysis
12.3 AI Imaging & Diagnostics Midstream Analysis
12.4 AI Imaging & Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global AI Imaging & Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global AI Imaging & Diagnostics Consumption Value by Diagnostic Data Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global AI Imaging & Diagnostics Consumption Value by Deployment & Delivery, (USD Million), 2021 & 2025 & 2032
Table 4. Global AI Imaging & Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global AI Imaging & Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global AI Imaging & Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Butterfly Network Company Information, Head Office, and Major Competitors
Table 8. Butterfly Network Major Business
Table 9. Butterfly Network AI Imaging & Diagnostics Product and Solutions
Table 10. Butterfly Network AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Butterfly Network Recent Developments and Future Plans
Table 12. Merative Company Information, Head Office, and Major Competitors
Table 13. Merative Major Business
Table 14. Merative AI Imaging & Diagnostics Product and Solutions
Table 15. Merative AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Merative Recent Developments and Future Plans
Table 17. Tempus Company Information, Head Office, and Major Competitors
Table 18. Tempus Major Business
Table 19. Tempus AI Imaging & Diagnostics Product and Solutions
Table 20. Tempus AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. RetinAi Company Information, Head Office, and Major Competitors
Table 22. RetinAi Major Business
Table 23. RetinAi AI Imaging & Diagnostics Product and Solutions
Table 24. RetinAi AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. RetinAi Recent Developments and Future Plans
Table 26. Nanox Company Information, Head Office, and Major Competitors
Table 27. Nanox Major Business
Table 28. Nanox AI Imaging & Diagnostics Product and Solutions
Table 29. Nanox AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Nanox Recent Developments and Future Plans
Table 31. Lunit Company Information, Head Office, and Major Competitors
Table 32. Lunit Major Business
Table 33. Lunit AI Imaging & Diagnostics Product and Solutions
Table 34. Lunit AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Lunit Recent Developments and Future Plans
Table 36. DiA Imaging Company Information, Head Office, and Major Competitors
Table 37. DiA Imaging Major Business
Table 38. DiA Imaging AI Imaging & Diagnostics Product and Solutions
Table 39. DiA Imaging AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. DiA Imaging Recent Developments and Future Plans
Table 41. Subtle Medical Company Information, Head Office, and Major Competitors
Table 42. Subtle Medical Major Business
Table 43. Subtle Medical AI Imaging & Diagnostics Product and Solutions
Table 44. Subtle Medical AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Subtle Medical Recent Developments and Future Plans
Table 46. BrainMiner Company Information, Head Office, and Major Competitors
Table 47. BrainMiner Major Business
Table 48. BrainMiner AI Imaging & Diagnostics Product and Solutions
Table 49. BrainMiner AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. BrainMiner Recent Developments and Future Plans
Table 51. GE Company Information, Head Office, and Major Competitors
Table 52. GE Major Business
Table 53. GE AI Imaging & Diagnostics Product and Solutions
Table 54. GE AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. GE Recent Developments and Future Plans
Table 56. Siemens Company Information, Head Office, and Major Competitors
Table 57. Siemens Major Business
Table 58. Siemens AI Imaging & Diagnostics Product and Solutions
Table 59. Siemens AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Siemens Recent Developments and Future Plans
Table 61. Aidoc Company Information, Head Office, and Major Competitors
Table 62. Aidoc Major Business
Table 63. Aidoc AI Imaging & Diagnostics Product and Solutions
Table 64. Aidoc AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Aidoc Recent Developments and Future Plans
Table 66. Imagen Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 67. Imagen Technologies, Inc. Major Business
Table 68. Imagen Technologies, Inc. AI Imaging & Diagnostics Product and Solutions
Table 69. Imagen Technologies, Inc. AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Imagen Technologies, Inc. Recent Developments and Future Plans
Table 71. VUNO, Inc. Company Information, Head Office, and Major Competitors
Table 72. VUNO, Inc. Major Business
Table 73. VUNO, Inc. AI Imaging & Diagnostics Product and Solutions
Table 74. VUNO, Inc. AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. VUNO, Inc. Recent Developments and Future Plans
Table 76. Digital Diagnostics Company Information, Head Office, and Major Competitors
Table 77. Digital Diagnostics Major Business
Table 78. Digital Diagnostics AI Imaging & Diagnostics Product and Solutions
Table 79. Digital Diagnostics AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Digital Diagnostics Recent Developments and Future Plans
Table 81. NeuraSignal Company Information, Head Office, and Major Competitors
Table 82. NeuraSignal Major Business
Table 83. NeuraSignal AI Imaging & Diagnostics Product and Solutions
Table 84. NeuraSignal AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. NeuraSignal Recent Developments and Future Plans
Table 86. Riverain Technologies, LLC Company Information, Head Office, and Major Competitors
Table 87. Riverain Technologies, LLC Major Business
Table 88. Riverain Technologies, LLC AI Imaging & Diagnostics Product and Solutions
Table 89. Riverain Technologies, LLC AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Riverain Technologies, LLC Recent Developments and Future Plans
Table 91. Philips Company Information, Head Office, and Major Competitors
Table 92. Philips Major Business
Table 93. Philips AI Imaging & Diagnostics Product and Solutions
Table 94. Philips AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Philips Recent Developments and Future Plans
Table 96. Microsoft Company Information, Head Office, and Major Competitors
Table 97. Microsoft Major Business
Table 98. Microsoft AI Imaging & Diagnostics Product and Solutions
Table 99. Microsoft AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Microsoft Recent Developments and Future Plans
Table 101. Viz.ai Company Information, Head Office, and Major Competitors
Table 102. Viz.ai Major Business
Table 103. Viz.ai AI Imaging & Diagnostics Product and Solutions
Table 104. Viz.ai AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Viz.ai Recent Developments and Future Plans
Table 106. RapidAI Company Information, Head Office, and Major Competitors
Table 107. RapidAI Major Business
Table 108. RapidAI AI Imaging & Diagnostics Product and Solutions
Table 109. RapidAI AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. RapidAI Recent Developments and Future Plans
Table 111. Canon Medical Company Information, Head Office, and Major Competitors
Table 112. Canon Medical Major Business
Table 113. Canon Medical AI Imaging & Diagnostics Product and Solutions
Table 114. Canon Medical AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Canon Medical Recent Developments and Future Plans
Table 116. Enlitic Company Information, Head Office, and Major Competitors
Table 117. Enlitic Major Business
Table 118. Enlitic AI Imaging & Diagnostics Product and Solutions
Table 119. Enlitic AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Enlitic Recent Developments and Future Plans
Table 121. BioMind Company Information, Head Office, and Major Competitors
Table 122. BioMind Major Business
Table 123. BioMind AI Imaging & Diagnostics Product and Solutions
Table 124. BioMind AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. BioMind Recent Developments and Future Plans
Table 126. ANNALISE-AI PTY LTD Company Information, Head Office, and Major Competitors
Table 127. ANNALISE-AI PTY LTD Major Business
Table 128. ANNALISE-AI PTY LTD AI Imaging & Diagnostics Product and Solutions
Table 129. ANNALISE-AI PTY LTD AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. ANNALISE-AI PTY LTD Recent Developments and Future Plans
Table 131. icometrix Company Information, Head Office, and Major Competitors
Table 132. icometrix Major Business
Table 133. icometrix AI Imaging & Diagnostics Product and Solutions
Table 134. icometrix AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. icometrix Recent Developments and Future Plans
Table 136. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Company Information, Head Office, and Major Competitors
Table 137. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Major Business
Table 138. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Imaging & Diagnostics Product and Solutions
Table 139. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Developments and Future Plans
Table 141. Global AI Imaging & Diagnostics Revenue (USD Million) by Players (2021-2026)
Table 142. Global AI Imaging & Diagnostics Revenue Share by Players (2021-2026)
Table 143. Breakdown of AI Imaging & Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 144. Market Position of Players in AI Imaging & Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 145. Head Office of Key AI Imaging & Diagnostics Players
Table 146. AI Imaging & Diagnostics Market: Company Product Type Footprint
Table 147. AI Imaging & Diagnostics Market: Company Product Application Footprint
Table 148. AI Imaging & Diagnostics New Market Entrants and Barriers to Market Entry
Table 149. AI Imaging & Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 150. Global AI Imaging & Diagnostics Consumption Value (USD Million) by Type (2021-2026)
Table 151. Global AI Imaging & Diagnostics Consumption Value Share by Type (2021-2026)
Table 152. Global AI Imaging & Diagnostics Consumption Value Forecast by Type (2027-2032)
Table 153. Global AI Imaging & Diagnostics Consumption Value by Application (2021-2026)
Table 154. Global AI Imaging & Diagnostics Consumption Value Forecast by Application (2027-2032)
Table 155. North America AI Imaging & Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 156. North America AI Imaging & Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 157. North America AI Imaging & Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 158. North America AI Imaging & Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 159. North America AI Imaging & Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 160. North America AI Imaging & Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 161. Europe AI Imaging & Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 162. Europe AI Imaging & Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 163. Europe AI Imaging & Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 164. Europe AI Imaging & Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 165. Europe AI Imaging & Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 166. Europe AI Imaging & Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 167. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 168. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 169. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 170. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 171. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 172. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 173. South America AI Imaging & Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 174. South America AI Imaging & Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 175. South America AI Imaging & Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 176. South America AI Imaging & Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 177. South America AI Imaging & Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 178. South America AI Imaging & Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 179. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 180. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 181. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 182. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 183. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 184. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 185. Global Key Players of AI Imaging & Diagnostics Upstream (Raw Materials)
Table 186. Global AI Imaging & Diagnostics Typical Customers
Table 1. Global AI Imaging & Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global AI Imaging & Diagnostics Consumption Value by Diagnostic Data Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global AI Imaging & Diagnostics Consumption Value by Deployment & Delivery, (USD Million), 2021 & 2025 & 2032
Table 4. Global AI Imaging & Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global AI Imaging & Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global AI Imaging & Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Butterfly Network Company Information, Head Office, and Major Competitors
Table 8. Butterfly Network Major Business
Table 9. Butterfly Network AI Imaging & Diagnostics Product and Solutions
Table 10. Butterfly Network AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Butterfly Network Recent Developments and Future Plans
Table 12. Merative Company Information, Head Office, and Major Competitors
Table 13. Merative Major Business
Table 14. Merative AI Imaging & Diagnostics Product and Solutions
Table 15. Merative AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Merative Recent Developments and Future Plans
Table 17. Tempus Company Information, Head Office, and Major Competitors
Table 18. Tempus Major Business
Table 19. Tempus AI Imaging & Diagnostics Product and Solutions
Table 20. Tempus AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. RetinAi Company Information, Head Office, and Major Competitors
Table 22. RetinAi Major Business
Table 23. RetinAi AI Imaging & Diagnostics Product and Solutions
Table 24. RetinAi AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. RetinAi Recent Developments and Future Plans
Table 26. Nanox Company Information, Head Office, and Major Competitors
Table 27. Nanox Major Business
Table 28. Nanox AI Imaging & Diagnostics Product and Solutions
Table 29. Nanox AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Nanox Recent Developments and Future Plans
Table 31. Lunit Company Information, Head Office, and Major Competitors
Table 32. Lunit Major Business
Table 33. Lunit AI Imaging & Diagnostics Product and Solutions
Table 34. Lunit AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Lunit Recent Developments and Future Plans
Table 36. DiA Imaging Company Information, Head Office, and Major Competitors
Table 37. DiA Imaging Major Business
Table 38. DiA Imaging AI Imaging & Diagnostics Product and Solutions
Table 39. DiA Imaging AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. DiA Imaging Recent Developments and Future Plans
Table 41. Subtle Medical Company Information, Head Office, and Major Competitors
Table 42. Subtle Medical Major Business
Table 43. Subtle Medical AI Imaging & Diagnostics Product and Solutions
Table 44. Subtle Medical AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Subtle Medical Recent Developments and Future Plans
Table 46. BrainMiner Company Information, Head Office, and Major Competitors
Table 47. BrainMiner Major Business
Table 48. BrainMiner AI Imaging & Diagnostics Product and Solutions
Table 49. BrainMiner AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. BrainMiner Recent Developments and Future Plans
Table 51. GE Company Information, Head Office, and Major Competitors
Table 52. GE Major Business
Table 53. GE AI Imaging & Diagnostics Product and Solutions
Table 54. GE AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. GE Recent Developments and Future Plans
Table 56. Siemens Company Information, Head Office, and Major Competitors
Table 57. Siemens Major Business
Table 58. Siemens AI Imaging & Diagnostics Product and Solutions
Table 59. Siemens AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Siemens Recent Developments and Future Plans
Table 61. Aidoc Company Information, Head Office, and Major Competitors
Table 62. Aidoc Major Business
Table 63. Aidoc AI Imaging & Diagnostics Product and Solutions
Table 64. Aidoc AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Aidoc Recent Developments and Future Plans
Table 66. Imagen Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 67. Imagen Technologies, Inc. Major Business
Table 68. Imagen Technologies, Inc. AI Imaging & Diagnostics Product and Solutions
Table 69. Imagen Technologies, Inc. AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Imagen Technologies, Inc. Recent Developments and Future Plans
Table 71. VUNO, Inc. Company Information, Head Office, and Major Competitors
Table 72. VUNO, Inc. Major Business
Table 73. VUNO, Inc. AI Imaging & Diagnostics Product and Solutions
Table 74. VUNO, Inc. AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. VUNO, Inc. Recent Developments and Future Plans
Table 76. Digital Diagnostics Company Information, Head Office, and Major Competitors
Table 77. Digital Diagnostics Major Business
Table 78. Digital Diagnostics AI Imaging & Diagnostics Product and Solutions
Table 79. Digital Diagnostics AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Digital Diagnostics Recent Developments and Future Plans
Table 81. NeuraSignal Company Information, Head Office, and Major Competitors
Table 82. NeuraSignal Major Business
Table 83. NeuraSignal AI Imaging & Diagnostics Product and Solutions
Table 84. NeuraSignal AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. NeuraSignal Recent Developments and Future Plans
Table 86. Riverain Technologies, LLC Company Information, Head Office, and Major Competitors
Table 87. Riverain Technologies, LLC Major Business
Table 88. Riverain Technologies, LLC AI Imaging & Diagnostics Product and Solutions
Table 89. Riverain Technologies, LLC AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Riverain Technologies, LLC Recent Developments and Future Plans
Table 91. Philips Company Information, Head Office, and Major Competitors
Table 92. Philips Major Business
Table 93. Philips AI Imaging & Diagnostics Product and Solutions
Table 94. Philips AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Philips Recent Developments and Future Plans
Table 96. Microsoft Company Information, Head Office, and Major Competitors
Table 97. Microsoft Major Business
Table 98. Microsoft AI Imaging & Diagnostics Product and Solutions
Table 99. Microsoft AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Microsoft Recent Developments and Future Plans
Table 101. Viz.ai Company Information, Head Office, and Major Competitors
Table 102. Viz.ai Major Business
Table 103. Viz.ai AI Imaging & Diagnostics Product and Solutions
Table 104. Viz.ai AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Viz.ai Recent Developments and Future Plans
Table 106. RapidAI Company Information, Head Office, and Major Competitors
Table 107. RapidAI Major Business
Table 108. RapidAI AI Imaging & Diagnostics Product and Solutions
Table 109. RapidAI AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. RapidAI Recent Developments and Future Plans
Table 111. Canon Medical Company Information, Head Office, and Major Competitors
Table 112. Canon Medical Major Business
Table 113. Canon Medical AI Imaging & Diagnostics Product and Solutions
Table 114. Canon Medical AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Canon Medical Recent Developments and Future Plans
Table 116. Enlitic Company Information, Head Office, and Major Competitors
Table 117. Enlitic Major Business
Table 118. Enlitic AI Imaging & Diagnostics Product and Solutions
Table 119. Enlitic AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Enlitic Recent Developments and Future Plans
Table 121. BioMind Company Information, Head Office, and Major Competitors
Table 122. BioMind Major Business
Table 123. BioMind AI Imaging & Diagnostics Product and Solutions
Table 124. BioMind AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. BioMind Recent Developments and Future Plans
Table 126. ANNALISE-AI PTY LTD Company Information, Head Office, and Major Competitors
Table 127. ANNALISE-AI PTY LTD Major Business
Table 128. ANNALISE-AI PTY LTD AI Imaging & Diagnostics Product and Solutions
Table 129. ANNALISE-AI PTY LTD AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. ANNALISE-AI PTY LTD Recent Developments and Future Plans
Table 131. icometrix Company Information, Head Office, and Major Competitors
Table 132. icometrix Major Business
Table 133. icometrix AI Imaging & Diagnostics Product and Solutions
Table 134. icometrix AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. icometrix Recent Developments and Future Plans
Table 136. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Company Information, Head Office, and Major Competitors
Table 137. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Major Business
Table 138. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Imaging & Diagnostics Product and Solutions
Table 139. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Imaging & Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Developments and Future Plans
Table 141. Global AI Imaging & Diagnostics Revenue (USD Million) by Players (2021-2026)
Table 142. Global AI Imaging & Diagnostics Revenue Share by Players (2021-2026)
Table 143. Breakdown of AI Imaging & Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 144. Market Position of Players in AI Imaging & Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 145. Head Office of Key AI Imaging & Diagnostics Players
Table 146. AI Imaging & Diagnostics Market: Company Product Type Footprint
Table 147. AI Imaging & Diagnostics Market: Company Product Application Footprint
Table 148. AI Imaging & Diagnostics New Market Entrants and Barriers to Market Entry
Table 149. AI Imaging & Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 150. Global AI Imaging & Diagnostics Consumption Value (USD Million) by Type (2021-2026)
Table 151. Global AI Imaging & Diagnostics Consumption Value Share by Type (2021-2026)
Table 152. Global AI Imaging & Diagnostics Consumption Value Forecast by Type (2027-2032)
Table 153. Global AI Imaging & Diagnostics Consumption Value by Application (2021-2026)
Table 154. Global AI Imaging & Diagnostics Consumption Value Forecast by Application (2027-2032)
Table 155. North America AI Imaging & Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 156. North America AI Imaging & Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 157. North America AI Imaging & Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 158. North America AI Imaging & Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 159. North America AI Imaging & Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 160. North America AI Imaging & Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 161. Europe AI Imaging & Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 162. Europe AI Imaging & Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 163. Europe AI Imaging & Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 164. Europe AI Imaging & Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 165. Europe AI Imaging & Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 166. Europe AI Imaging & Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 167. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 168. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 169. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 170. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 171. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 172. Asia-Pacific AI Imaging & Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 173. South America AI Imaging & Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 174. South America AI Imaging & Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 175. South America AI Imaging & Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 176. South America AI Imaging & Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 177. South America AI Imaging & Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 178. South America AI Imaging & Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 179. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 180. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 181. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 182. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 183. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 184. Middle East & Africa AI Imaging & Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 185. Global Key Players of AI Imaging & Diagnostics Upstream (Raw Materials)
Table 186. Global AI Imaging & Diagnostics Typical Customers
LIST OF FIGURES
Figure 1. AI Imaging & Diagnostics Picture
Figure 2. Global AI Imaging & Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global AI Imaging & Diagnostics Consumption Value Market Share by Type in 2025
Figure 4. X-ray / CXR
Figure 5. CT
Figure 6. MRI
Figure 7. Ultrasound
Figure 8. Mammography / DBT
Figure 9. Others
Figure 10. Global AI Imaging & Diagnostics Consumption Value by Diagnostic Data Type, (USD Million), 2021 & 2025 & 2032
Figure 11. Global AI Imaging & Diagnostics Consumption Value Market Share by Diagnostic Data Type in 2025
Figure 12. Medical Imaging–based
Figure 13. Physiological Signals–based
Figure 14. Ophthalmic Imaging–based
Figure 15. Others
Figure 16. Global AI Imaging & Diagnostics Consumption Value by Deployment & Delivery, (USD Million), 2021 & 2025 & 2032
Figure 17. Global AI Imaging & Diagnostics Consumption Value Market Share by Deployment & Delivery in 2025
Figure 18. On-prem
Figure 19. Cloud SaaS
Figure 20. Edge / Embedded
Figure 21. Hybrid
Figure 22. Others
Figure 23. Global AI Imaging & Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 24. AI Imaging & Diagnostics Consumption Value Market Share by Application in 2025
Figure 25. Radiology & Imaging Picture
Figure 26. Cardiology Picture
Figure 27. Neurology Picture
Figure 28. Ophthalmology Picture
Figure 29. Oncology Picture
Figure 30. Primary Care Picture
Figure 31. Others Picture
Figure 32. Global AI Imaging & Diagnostics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 33. Global AI Imaging & Diagnostics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 34. Global Market AI Imaging & Diagnostics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 35. Global AI Imaging & Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 36. Global AI Imaging & Diagnostics Consumption Value Market Share by Region in 2025
Figure 37. North America AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 38. Europe AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 39. Asia-Pacific AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 40. South America AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 41. Middle East & Africa AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 42. Company Three Recent Developments and Future Plans
Figure 43. Global AI Imaging & Diagnostics Revenue Share by Players in 2025
Figure 44. AI Imaging & Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 45. Market Share of AI Imaging & Diagnostics by Player Revenue in 2025
Figure 46. Top 3 AI Imaging & Diagnostics Players Market Share in 2025
Figure 47. Top 6 AI Imaging & Diagnostics Players Market Share in 2025
Figure 48. Global AI Imaging & Diagnostics Consumption Value Share by Type (2021-2026)
Figure 49. Global AI Imaging & Diagnostics Market Share Forecast by Type (2027-2032)
Figure 50. Global AI Imaging & Diagnostics Consumption Value Share by Application (2021-2026)
Figure 51. Global AI Imaging & Diagnostics Market Share Forecast by Application (2027-2032)
Figure 52. North America AI Imaging & Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 53. North America AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 54. North America AI Imaging & Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 55. United States AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 56. Canada AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 57. Mexico AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 58. Europe AI Imaging & Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 59. Europe AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 60. Europe AI Imaging & Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 61. Germany AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 62. France AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 63. United Kingdom AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 64. Russia AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 65. Italy AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 66. Asia-Pacific AI Imaging & Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 67. Asia-Pacific AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 68. Asia-Pacific AI Imaging & Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 69. China AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 70. Japan AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 71. South Korea AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 72. India AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 73. Southeast Asia AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 74. Australia AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 75. South America AI Imaging & Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 76. South America AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 77. South America AI Imaging & Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 78. Brazil AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 79. Argentina AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 80. Middle East & Africa AI Imaging & Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 81. Middle East & Africa AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 82. Middle East & Africa AI Imaging & Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 83. Turkey AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 85. UAE AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 86. AI Imaging & Diagnostics Market Drivers
Figure 87. AI Imaging & Diagnostics Market Restraints
Figure 88. AI Imaging & Diagnostics Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. AI Imaging & Diagnostics Industrial Chain
Figure 91. Methodology
Figure 92. Research Process and Data Source
Figure 1. AI Imaging & Diagnostics Picture
Figure 2. Global AI Imaging & Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global AI Imaging & Diagnostics Consumption Value Market Share by Type in 2025
Figure 4. X-ray / CXR
Figure 5. CT
Figure 6. MRI
Figure 7. Ultrasound
Figure 8. Mammography / DBT
Figure 9. Others
Figure 10. Global AI Imaging & Diagnostics Consumption Value by Diagnostic Data Type, (USD Million), 2021 & 2025 & 2032
Figure 11. Global AI Imaging & Diagnostics Consumption Value Market Share by Diagnostic Data Type in 2025
Figure 12. Medical Imaging–based
Figure 13. Physiological Signals–based
Figure 14. Ophthalmic Imaging–based
Figure 15. Others
Figure 16. Global AI Imaging & Diagnostics Consumption Value by Deployment & Delivery, (USD Million), 2021 & 2025 & 2032
Figure 17. Global AI Imaging & Diagnostics Consumption Value Market Share by Deployment & Delivery in 2025
Figure 18. On-prem
Figure 19. Cloud SaaS
Figure 20. Edge / Embedded
Figure 21. Hybrid
Figure 22. Others
Figure 23. Global AI Imaging & Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 24. AI Imaging & Diagnostics Consumption Value Market Share by Application in 2025
Figure 25. Radiology & Imaging Picture
Figure 26. Cardiology Picture
Figure 27. Neurology Picture
Figure 28. Ophthalmology Picture
Figure 29. Oncology Picture
Figure 30. Primary Care Picture
Figure 31. Others Picture
Figure 32. Global AI Imaging & Diagnostics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 33. Global AI Imaging & Diagnostics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 34. Global Market AI Imaging & Diagnostics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 35. Global AI Imaging & Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 36. Global AI Imaging & Diagnostics Consumption Value Market Share by Region in 2025
Figure 37. North America AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 38. Europe AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 39. Asia-Pacific AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 40. South America AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 41. Middle East & Africa AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 42. Company Three Recent Developments and Future Plans
Figure 43. Global AI Imaging & Diagnostics Revenue Share by Players in 2025
Figure 44. AI Imaging & Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 45. Market Share of AI Imaging & Diagnostics by Player Revenue in 2025
Figure 46. Top 3 AI Imaging & Diagnostics Players Market Share in 2025
Figure 47. Top 6 AI Imaging & Diagnostics Players Market Share in 2025
Figure 48. Global AI Imaging & Diagnostics Consumption Value Share by Type (2021-2026)
Figure 49. Global AI Imaging & Diagnostics Market Share Forecast by Type (2027-2032)
Figure 50. Global AI Imaging & Diagnostics Consumption Value Share by Application (2021-2026)
Figure 51. Global AI Imaging & Diagnostics Market Share Forecast by Application (2027-2032)
Figure 52. North America AI Imaging & Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 53. North America AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 54. North America AI Imaging & Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 55. United States AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 56. Canada AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 57. Mexico AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 58. Europe AI Imaging & Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 59. Europe AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 60. Europe AI Imaging & Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 61. Germany AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 62. France AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 63. United Kingdom AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 64. Russia AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 65. Italy AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 66. Asia-Pacific AI Imaging & Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 67. Asia-Pacific AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 68. Asia-Pacific AI Imaging & Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 69. China AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 70. Japan AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 71. South Korea AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 72. India AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 73. Southeast Asia AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 74. Australia AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 75. South America AI Imaging & Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 76. South America AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 77. South America AI Imaging & Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 78. Brazil AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 79. Argentina AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 80. Middle East & Africa AI Imaging & Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 81. Middle East & Africa AI Imaging & Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 82. Middle East & Africa AI Imaging & Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 83. Turkey AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 85. UAE AI Imaging & Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 86. AI Imaging & Diagnostics Market Drivers
Figure 87. AI Imaging & Diagnostics Market Restraints
Figure 88. AI Imaging & Diagnostics Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. AI Imaging & Diagnostics Industrial Chain
Figure 91. Methodology
Figure 92. Research Process and Data Source
